Tools to evaluate estrogenic potency of dietary phytoestrogens:A consensus paper from the EU Thematic Network "Phytohealth" (QLKI-2002-2453).

PubWeight™: 0.75‹?›

🔗 View Article (PMC 3454835)

Published in Genes Nutr on September 01, 2006

Authors

N M Saarinen1, C Bingham, S Lorenzetti, A Mortensen, S Mäkelä, P Penttinen, I K Sørensen, L M Valsta, F Virgili, G Vollmer, A Wärri, O Zierau

Author Affiliations

1: Functional Foods Forum, University of Turku, Itäinen Pitkäkatu 4A, FI-20520, Turku, Finland, nisaarin@utu.fi.

Articles cited by this

(truncated to the top 100)

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science (1995) 10.42

Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology (1997) 10.08

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell (1998) 9.96

Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology (1998) 9.57

Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci U S A (1998) 5.86

The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ Health Perspect (1995) 5.37

Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development (2000) 5.03

Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev (2004) 3.74

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. N Engl J Med (2003) 3.46

Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem (2001) 3.24

An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia (2000) 2.73

Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci U S A (2004) 2.64

Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology (2003) 2.63

Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol (2003) 2.38

Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol (2003) 2.17

Estrogen receptor-beta is critical to granulosa cell differentiation and the ovulatory response to gonadotropins. Endocrinology (2005) 2.15

Estrogen receptor-dependent genomic responses in the uterus mirror the biphasic physiological response to estrogen. Mol Endocrinol (2003) 2.12

Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem (2006) 2.03

The rodent uterotrophic assay: critical protocol features, studies with nonyl phenols, and comparison with a yeast estrogenicity assay. Regul Toxicol Pharmacol (1997) 1.99

To ERR in the estrogen pathway. Trends Endocrinol Metab (2002) 1.97

Animal models impacted by phytoestrogens in commercial chow: implications for pathways influenced by hormones. Lab Invest (2001) 1.96

Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta. Endocrinology (1999) 1.93

Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci (2004) 1.92

Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res (1996) 1.91

Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ Health Perspect (1996) 1.87

Peptide antagonists of the human estrogen receptor. Science (1999) 1.86

Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res (1985) 1.81

The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies. Environ Health Perspect (2003) 1.80

Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia (2002) 1.79

Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol (1995) 1.75

Reflections on the discovery and significance of estrogen receptor beta. Endocr Rev (2005) 1.75

Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology (2002) 1.74

Phytoestrogen content of purified, open- and closed-formula laboratory animal diets. Lab Anim Sci (1999) 1.73

Response-specific and ligand dose-dependent modulation of estrogen receptor (ER) alpha activity by ERbeta in the uterus. Endocrinology (2003) 1.66

Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene (2005) 1.65

Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environ Health Perspect (2000) 1.63

Estrogenic activity of octylphenol, nonylphenol, bisphenol A and methoxychlor in rats. Toxicol Sci (2000) 1.60

Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study(1-4). J Nutr (2001) 1.55

Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem (2000) 1.54

Comparative analyses of mechanistic differences among antiestrogens. Endocrinology (1999) 1.52

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta. Proc Natl Acad Sci U S A (1999) 1.52

Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J (2002) 1.51

Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-alpha and estrogen receptor-beta: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology (2000) 1.50

Estrogen receptor-related receptors: orphan receptors desperately seeking a ligand. J Mol Endocrinol (2003) 1.48

Isoflavone content of infant formulas and the metabolic fate of these phytoestrogens in early life. Am J Clin Nutr (1998) 1.45

Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev (2004) 1.41

Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol (2001) 1.40

Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem (2006) 1.39

Selecting the appropriate rodent diet for endocrine disruptor research and testing studies. ILAR J (2004) 1.39

Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems. Endocrinology (1979) 1.32

Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol Cancer Res (2003) 1.32

Food labeling: health claims; soy protein and coronary heart disease. Food and Drug Administration, HHS. Final rule. Fed Regist (1999) 1.29

Bioavailability of phyto-oestrogens. Br J Nutr (2003) 1.28

Phytoestrogens: recent developments. Planta Med (2003) 1.27

Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer. Mol Endocrinol (1998) 1.27

Rapid screening of environmental chemicals for estrogen receptor binding capacity. Environ Health Perspect (1998) 1.27

The Molecular Pharmacology of SERMs. Trends Endocrinol Metab (1999) 1.25

In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem (2001) 1.25

Experimentally induced mammary tumors in rats. Breast Cancer Res Treat (1996) 1.22

Biological role of estrogen and estrogen receptors. Crit Rev Biochem Mol Biol (2002) 1.19

In vitro growth and ovulation of follicles from ovaries of estrogen receptor (ER){alpha} and ER{beta} null mice indicate a role for ER{beta} in follicular maturation. Endocrinology (2005) 1.19

In vitro bioassays of non-steroidal phytoestrogens. J Steroid Biochem Mol Biol (1993) 1.17

New screening methods for chemicals with hormonal activities using interaction of nuclear hormone receptor with coactivator. Toxicol Appl Pharmacol (1999) 1.16

Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control (2000) 1.14

Estrogenic and antiandrogenic activities of 17 benzophenone derivatives used as UV stabilizers and sunscreens. Toxicol Appl Pharmacol (2005) 1.13

Lignan contents of Dutch plant foods: a database including lariciresinol, pinoresinol, secoisolariciresinol and matairesinol. Br J Nutr (2005) 1.11

Estrogenic isoflavones in rodent diets. Toxicol Lett (2002) 1.11

Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer (2004) 1.08

The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med (1998) 1.08

Isoflavonoid and lignan phytoestrogens as dietary biomarkers. J Nutr (2003) 1.07

Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design. Mol Endocrinol (2004) 1.07

Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor. Mol Endocrinol (1999) 1.06

The mouse bioassay for the detection of estrogenic activity in rodent diets: II. Comparative estrogenic activity of purified, certified and standard open and closed formula rodent diets. Lab Anim Sci (1987) 1.06

Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol Endocrinol (1996) 1.06

Dietary phytoestrogen, serum enterolactone and risk of prostate cancer: the cancer prostate Sweden study (Sweden). Cancer Causes Control (2006) 1.05

The need to decide if all estrogens are intrinsically similar. Environ Health Perspect (2004) 1.03

The differential ability of the phytoestrogen genistein and of estradiol to induce uterine weight and proliferation in the rat is associated with a substance specific modulation of uterine gene expression. Mol Cell Endocrinol (2004) 1.01

Impact of isotype-selective estrogen receptor agonists on ovarian function. Proc Natl Acad Sci U S A (2004) 1.01

Novel estrogen response elements identified by genetic selection in yeast are differentially responsive to estrogens and antiestrogens in mammalian cells. Mol Endocrinol (1994) 1.01

Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues. J Steroid Biochem Mol Biol (2000) 1.01

Health effects of phytoestrogens. Forum Nutr (2005) 0.97

Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr (2002) 0.96

Normal sexual development of two strains of rat exposed in utero to low doses of bisphenol A. Toxicol Sci (2002) 0.96

Effects of flavonoids on aromatase activity, an in vitro study. J Steroid Biochem Mol Biol (1996) 0.95

Assessing estrogenic activity of phytochemicals using transcriptional activation and immature mouse uterotrophic responses. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.95

Isoflavone intake in four different European countries: the VENUS approach. Br J Nutr (2003) 0.95

Quantitative characterization of the interaction between purified human estrogen receptor alpha and DNA using fluorescence anisotropy. Nucleic Acids Res (2000) 0.94

Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes. Mol Endocrinol (1990) 0.94

Overview of in vitro tools to assess the estrogenic and antiestrogenic activity of phytoestrogens. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.93

Interaction of human estrogen receptors alpha and beta with the same naturally occurring estrogen response elements. Biochem Pharmacol (1999) 0.93

Intake of the plant lignans secoisolariciresinol, matairesinol, lariciresinol, and pinoresinol in Dutch men and women. J Nutr (2005) 0.93

Reproductive phenotypes in the estrogen receptor-alpha knockout mouse. Ann Endocrinol (Paris) (1999) 0.92

Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum Reprod (2001) 0.92

Dietary factors affecting uterine weights of immature CD-1 mice used in uterotrophic bioassays. Cancer Detect Prev (2002) 0.91

Phyto-oestrogen database of foods and average intake in Finland. Br J Nutr (2003) 0.91

Xenoendocrine disrupters-tiered screening and testing: filling key data gaps. Toxicology (2002) 0.90

Inhibition of 17beta-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc Soc Exp Biol Med (1998) 0.88

Cell response endpoints enhance sensitivity of the immature mouse uterotropic assay. Reprod Toxicol (2001) 0.87

Flavonoids can block PSA production by breast and prostate cancer cell lines. Clin Chim Acta (2002) 0.86

Sex steroid receptor regulation by genistein in the prepubertal rat uterus. Mol Cell Endocrinol (2001) 0.86

Articles by these authors

Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med (2013) 7.51

Mechanisms of estrogen action. Physiol Rev (2001) 5.97

Inferential statistical methods for estimating and comparing cosinor parameters. Chronobiologia (1983) 2.52

Mutations in hepatocyte nuclear factor-1beta and their related phenotypes. J Med Genet (2005) 2.24

Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors. Cancer Res (2001) 2.21

Clinical and pharmacological determinants of the therapeutic response to dihydroartemisinin-piperaquine for drug-resistant malaria. Antimicrob Agents Chemother (2007) 2.02

Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia (1996) 1.69

A case of a laboratory animal feed with high estrogenic activity and its impact on in vivo responses to exogenously administered estrogens. Environ Health Perspect (1998) 1.55

Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci U S A (2001) 1.55

Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med (1999) 1.49

beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes (2001) 1.47

Evaluation of the Emu-pim-1 transgenic mouse model for short-term carcinogenicity testing. Toxicol Pathol (1999) 1.42

Estrogen receptor beta in breast cancer. Endocr Relat Cancer (2002) 1.41

Developmental estrogenization and prostatic neoplasia. Prostate (1994) 1.39

Hepatocyte nuclear factor-1beta: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol (2001) 1.36

Vitamin D deficiency and bone health in healthy adults in Finland: could this be a concern in other parts of Europe? J Bone Miner Res (2001) 1.35

The natural history of exercise-induced anaphylaxis: survey results from a 10-year follow-up study. J Allergy Clin Immunol (1999) 1.29

Modulation of cytokine expression by CD4+ T cells during coxsackievirus B3 infections of BALB/c mice initiated by cells expressing the gamma delta + T-cell receptor. J Virol (1996) 1.23

Sodium in the Finnish diet: II trends in dietary sodium intake and comparison between intake and 24-h excretion of sodium. Eur J Clin Nutr (2006) 1.23

Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology (2001) 1.20

Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1beta in human pancreatic development. Diabet Med (2006) 1.18

Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol (2004) 1.16

The mutated human gene encoding hepatocyte nuclear factor 1beta inhibits kidney formation in developing Xenopus embryos. Proc Natl Acad Sci U S A (2000) 1.16

Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity. J Steroid Biochem Mol Biol (2000) 1.15

Surveillance trends of the 2009 influenza A(H1N1) pandemic in Europe. Euro Surveill (2011) 1.10

Common clinical indices of thyroid hormone action: relationships to serum free 3,5,3'-triiodothyronine concentration and estimated nuclear occupancy. J Clin Endocrinol Metab (1980) 1.10

Resonance of about-weekly human heart rate rhythm with solar activity change. Biologia (Bratisl) (1996) 1.08

'Did you have flu last week?' A telephone survey to estimate a point prevalence of influenza in the Swedish population. Euro Surveill (2005) 1.08

Sumatriptan is a potent vasoconstrictor of human dural arteries via a 5-HT1-like receptor. Cephalalgia (1992) 1.07

Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect (2000) 1.07

Start of the 2014/15 influenza season in Europe: drifted influenza A(H3N2) viruses circulate as dominant subtype. Euro Surveill (2015) 1.07

Wood-derived estrogens: studies in vitro with breast cancer cell lines and in vivo in trout. Toxicol Appl Pharmacol (1996) 1.06

Influenza-related deaths--available methods for estimating numbers and detecting patterns for seasonal and pandemic influenza in Europe. Euro Surveill (2012) 1.06

Food intake, feeding rhythm, and body mass regulation in Svalbard rock ptarmigan. Am J Physiol (1986) 1.06

Determinants of serum enterolactone concentration. Am J Clin Nutr (2001) 1.05

The effect of zinc and vitamin A supplementation on immune response in an older population. J Am Geriatr Soc (1998) 1.04

Comparing introduction to Europe of highly pathogenic avian influenza viruses A(H5N8) in 2014 and A(H5N1) in 2005. Euro Surveill (2014) 1.03

Associations of dietary polyunsaturated fatty acids with bone mineral density in elderly women. Eur J Clin Nutr (2011) 1.00

Regulation of progesterone receptors and decidualization in uterine stroma of the estrogen receptor-alpha knockout mouse. Biol Reprod (2001) 0.99

Co-localization of androgen receptor with estrogen receptor beta in the lower urinary tract of the male rat. J Urol (2001) 0.98

Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. Int J Cancer (1992) 0.98

Upregulation of CFTR expression but not SLC26A3 and SLC9A3 in ulcerative colitis. Am J Physiol Gastrointest Liver Physiol (2002) 0.98

Chronobiologic serial sections of several orders. Chronobiologia (1983) 0.98

Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides (1998) 0.97

No evidence for the in vivo activity of aromatase-inhibiting flavonoids. J Steroid Biochem Mol Biol (2001) 0.97

Abnormal splicing of hepatocyte nuclear factor-1 beta in the renal cysts and diabetes syndrome. Diabetologia (2004) 0.96

High dietary omega-6 polyunsaturated fatty acids drastically increase the formation of etheno-DNA base adducts in white blood cells of female subjects. Cancer Epidemiol Biomarkers Prev (1997) 0.94

Determination of DNA adducts of malonaldehyde in humans: effects of dietary fatty acid composition. Carcinogenesis (1996) 0.94

Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. Mol Cell Biol Res Commun (2000) 0.94

Type 2 diabetes: one disease, multiple cardiovascular risk factors. Coron Artery Dis (1999) 0.93

Folate intake, plasma folate and homocysteine status in a random Finnish population. Eur J Clin Nutr (2003) 0.93

Catecholestrogens are MCF-7 cell estrogen receptor agonists. J Steroid Biochem Mol Biol (1993) 0.93

Animal models for the preneoplastic lesions of the prostate. Eur Urol (1996) 0.92

GRB 130427A: a nearby ordinary monster. Science (2013) 0.92

Localization of oestrogen receptors alpha and beta in human testis. Mol Hum Reprod (2001) 0.92

Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum Reprod (2001) 0.92

[Thyroid hemiaplasia]. Nord Med (1967) 0.91

An outbreak of mumps in Sweden, February-April 2004. Euro Surveill (2005) 0.91

Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens. Arch Toxicol (2003) 0.91

Beyond circadian chronorisk: worldwide circaseptan-circasemiseptan patterns of myocardial infarctions, other vascular events, and emergencies. Chronobiologia (1993) 0.90

Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study. Eur J Clin Nutr (2012) 0.90

Genistein exerts estrogen-like effects in male mouse reproductive tract. Mol Cell Endocrinol (1998) 0.90

Cross-spectral coherence between geomagnetic disturbance and human cardiovascular variables at non-societal frequencies. Chronobiologia (1995) 0.89

Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns. J Nutrigenet Nutrigenomics (2009) 0.89

An in vitro model of proliferation and differentiation of the chick retina: coaggregates of retinal and pigment epithelial cells. J Neurosci (1986) 0.89

(R)-N-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid binds with high affinity to the brain gamma-aminobutyric acid uptake carrier. J Neurochem (1990) 0.89

High pentraxin-3 plasma levels associate with thrombocytopenia in acute Puumala hantavirus-induced nephropathia epidemica. Eur J Clin Microbiol Infect Dis (2011) 0.88

Prostatic dysplasia associated with increased expression of c-myc in neonatally estrogenized mice. J Urol (1993) 0.88

Tenascin-C in serum: a questionable tumor marker. Int J Cancer (1995) 0.88

Role of endothelium and nitric oxide in histamine-induced responses in human cranial arteries and detection of mRNA encoding H1- and H2-receptors by RT-PCR. Br J Pharmacol (1997) 0.88

Quantitative investigation of hepatic genomic response to hormonal and pathophysiological stimuli by multivariate analysis of two-dimensional mRNA activity profiles. Proc Natl Acad Sci U S A (1984) 0.88

Kidney disease in hypomelanosis of Ito. Nephrol Dial Transplant (2001) 0.87

Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene. Int J Cancer (1993) 0.87

The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. Cancer Lett (1998) 0.87

Enter the Web: an experiment in electronic research peer review. Med J Aust (1996) 0.87

Influence of cocaine use on cigarette smoking. JAMA (1994) 0.86

A public-private partnership for TB control in Timika, Papua Province, Indonesia. Int J Tuberc Lung Dis (2007) 0.86

Validity and reproducibility of the NORBAGREEN food frequency questionnaire. Eur J Clin Nutr (2007) 0.86

Characterization of HuH6, Hep3B, HepG2 and HLE liver cancer cell lines by WNT/β - catenin pathway, microRNA expression and protein expression profile. Cell Mol Biol (Noisy-le-grand) (2010) 0.86

The determination of naproxen by spectrofluorometry and its binding to serum proteins. Acta Pharmacol Toxicol (Copenh) (1979) 0.85

Laminin mediates basement membrane induced differentiation of HEC 1B endometrial adenocarcinoma cells. Biochem Cell Biol (1996) 0.85

Relative expansion of extracellular water in obese vs. normal children. J Appl Physiol (1985) (1995) 0.85

Polypropylene mesh hernia repair--an alternative permitting rapid return to peritoneal dialysis. Nephrol Dial Transplant (1998) 0.85

A novel basement membrane-induced gene identified in the human endometrial adenocarcinoma cell line HEC1B. FEBS Lett (1998) 0.84

Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies). Nutr Cancer (2000) 0.84

Estrogenic properties of isoflavones derived from Millettia griffoniana. Phytomedicine (2005) 0.84

From experimental units to unique experiments: chronobiologic pilots complement large trials. In Vivo (1992) 0.84

Dietary phytoestrogens and their role in hormonally dependent disease. Toxicol Lett (1998) 0.84

Reaggregation of embryonic chick retina cells: pigment epithelial cells induce a high order of stratification. Neurosci Lett (1984) 0.84

Basic Surveillance Network, a European database for surveillance data on infectious diseases. Euro Surveill (2004) 0.84

Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria. Kidney Int Suppl (1997) 0.84

The acute effects of mono(2-ethylhexyl)phthalate (MEHP) on testes of prepubertal Wistar rats. Toxicol Lett (2001) 0.83

Microalbuminuria as a screening tool in cystic fibrosis-related diabetes. Pediatr Pulmonol (2005) 0.83

The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. Diabetes Care (1984) 0.83

Selective changes in DNA binding activity of transcription factors in UM-X7.1 cardiomyopathic hamsters. Life Sci (2002) 0.83

Phytoestrogens: potential endocrine disruptors in males. Toxicol Ind Health (1998) 0.83

Nontraumatic urethral dyssynergia in neonatally estrogenized male rats. J Urol (2001) 0.83

Comparison of the effects of two diets rich in monounsaturated fatty acids differing in their linoleic/alpha-linolenic acid ratio on platelet aggregation. Thromb Haemost (1994) 0.83